Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Flowers

Showing results (11-20 of 430) with videos related to

Pageof 43
Sort By:
Leukemia & Lymphoma|November 4, 2020
How should clinicians interpret conflicting cost-effectiveness analyses for the treatment of lymphoma across nations and payer models?R Andrew Harkins, Christopher R Flowers
Expert Review of Pharmacoeconomics & Outcomes Research|March 1, 2018
Balancing patient value and payer cost in hematologic malignancies: can it be done?Pamela B Allen, Christopher R Flowers
JAMA Network Open|January 16, 2019
Identifying and Addressing Disparities in Survival Outcomes for Rural Patients With CancerLauren E McCullough, Christopher R Flowers
Oncology (Williston Park, N.Y.)|July 17, 2015
A Plethora of Novel Therapies--Which One to Choose?Jonathon B Cohen, Christopher R Flowers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2018
What Can Cost-Effectiveness Analysis Tell Us About Chimeric Antigen Receptor T-Cell Therapy for Relapsed Acute Lymphoblastic Leukemia?Christopher R Flowers, Scott D Ramsey
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2010
A decade of progress in lymphoma: advances and continuing challengesChristopher R Flowers, James O Armitage
Blood|January 9, 2016
Identifying risk factors for B-cell lymphomaChristopher R Flowers, Christine F Skibola
Cancer|May 3, 2017
Prognostic modeling in diffuse large B-cell lymphoma in the era of immunochemotherapy: Where do we go from here?Jean L Koff, Christopher R Flowers
Hematology. American Society of Hematology. Education Program|February 20, 2015
Optimal disease surveillance strategies in non-Hodgkin lymphomaJonathon B Cohen, Christopher R Flowers
Community Oncology|January 15, 2013
Management of relapsed chronic lymphocytic leukemia: applying guidelines to practiceLoretta J Nastoupil, Christopher R Flowers
Pageof 43

Showing results (11-20 of 430) with videos related to

Sort By:
Pageof 43
Leukemia & Lymphoma|November 4, 2020
How should clinicians interpret conflicting cost-effectiveness analyses for the treatment of lymphoma across nations and payer models?R Andrew Harkins, Christopher R Flowers
Expert Review of Pharmacoeconomics & Outcomes Research|March 1, 2018
Balancing patient value and payer cost in hematologic malignancies: can it be done?Pamela B Allen, Christopher R Flowers
JAMA Network Open|January 16, 2019
Identifying and Addressing Disparities in Survival Outcomes for Rural Patients With CancerLauren E McCullough, Christopher R Flowers
Oncology (Williston Park, N.Y.)|July 17, 2015
A Plethora of Novel Therapies--Which One to Choose?Jonathon B Cohen, Christopher R Flowers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2018
What Can Cost-Effectiveness Analysis Tell Us About Chimeric Antigen Receptor T-Cell Therapy for Relapsed Acute Lymphoblastic Leukemia?Christopher R Flowers, Scott D Ramsey
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2010
A decade of progress in lymphoma: advances and continuing challengesChristopher R Flowers, James O Armitage
Blood|January 9, 2016
Identifying risk factors for B-cell lymphomaChristopher R Flowers, Christine F Skibola
Cancer|May 3, 2017
Prognostic modeling in diffuse large B-cell lymphoma in the era of immunochemotherapy: Where do we go from here?Jean L Koff, Christopher R Flowers
Hematology. American Society of Hematology. Education Program|February 20, 2015
Optimal disease surveillance strategies in non-Hodgkin lymphomaJonathon B Cohen, Christopher R Flowers
Community Oncology|January 15, 2013
Management of relapsed chronic lymphocytic leukemia: applying guidelines to practiceLoretta J Nastoupil, Christopher R Flowers
Pageof 43